Natalia Frattarelli

Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia

Enrico Tiacci, Edoardo Simonetti, Monia Capponi et al. · New England Journal of Medicine · 2021 · 122 citations

Medicine, Oncology, Pharmacotherapy +13

THE BRAF INHIBITOR VEMURAFENIB PLUS RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE RESPONSES IN RELAPSED/REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE‐2 TRIAL

Enrico Tiacci, Luca De Carolis, Edoardo Simonetti et al. · Hematological Oncology · 2019 · 26 citations

Medicine, Oncology, Pharmacology +11

Stage I/II follicular lymphoma: spread of bcl‐2/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy

Alessandro Pulsoni, Irene Della Starza, Natalia Frattarelli et al. · British Journal of Haematology · 2007 · 22 citations

Medicine, Hematology, Oncology +17

Conservative treatment for patients over 80 years with acute myelogenous leukemia

Roberto Latagliata, Giuliana Alimena, Ida Carmosino et al. · American Journal of Hematology · 2002 · 14 citations · Full text

Medicine, Hematology, Oncology +15

Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkinlymphoma

Elena Cavalieri, Angela Matturro, Giorgia Annechini et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 13 citations

Medicine, Hematology, Oncology +16